- Home
- CNH vs BBIO Comparison
CNH vs BBIO Comparison
Compare CNH & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNH
- BBIO
- Stock Information
- Founded
- CNH 1842
- BBIO 2015
- Country
- CNH United Kingdom
- BBIO United States
- Employees
- CNH N/A
- BBIO N/A
- Industry
- CNH Construction/Ag Equipment/Trucks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CNH Industrials
- BBIO Health Care
- Exchange
- CNH Nasdaq
- BBIO Nasdaq
- Market Cap
- CNH 12.6B
- BBIO 10.4B
- IPO Year
- CNH N/A
- BBIO 2019
- Fundamental
- Price
- CNH $9.63
- BBIO $61.73
- Analyst Decision
- CNH Buy
- BBIO Strong Buy
- Analyst Count
- CNH 11
- BBIO 18
- Target Price
- CNH $14.50
- BBIO $74.28
- AVG Volume (30 Days)
- CNH 13.4M
- BBIO 2.7M
- Earning Date
- CNH 11-07-2025
- BBIO 10-29-2025
- Dividend Yield
- CNH 2.59%
- BBIO N/A
- EPS Growth
- CNH N/A
- BBIO N/A
- EPS
- CNH 0.48
- BBIO N/A
- Revenue
- CNH $17,814,000,000.00
- BBIO $353,780,000.00
- Revenue This Year
- CNH N/A
- BBIO $123.32
- Revenue Next Year
- CNH $2.21
- BBIO $73.46
- P/E Ratio
- CNH $20.22
- BBIO N/A
- Revenue Growth
- CNH N/A
- BBIO 62.46
- 52 Week Low
- CNH $9.00
- BBIO $21.72
- 52 Week High
- CNH $14.27
- BBIO $69.48
- Technical
- Relative Strength Index (RSI)
- CNH 28.58
- BBIO 59.65
- Support Level
- CNH $10.18
- BBIO $60.23
- Resistance Level
- CNH $10.61
- BBIO $64.44
- Average True Range (ATR)
- CNH 0.31
- BBIO 3.05
- MACD
- CNH -0.04
- BBIO 0.06
- Stochastic Oscillator
- CNH 30.41
- BBIO 53.68
About CNH CNH Industrial N.V.
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.